MASS - NASDAQ

908 Devices Inc.

MASS·NASDAQ

$8.66

-2.1%

HealthcareMedical - Devices

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$327.47M

EPS0.5400

P/E Ratio16.04

Earnings Date08/04/2026

mass

Net Interest Income

Last Annual Value

816.00K

3-Year CAGR

-25%

5-Year CAGR

23%

10-Year CAGR

10%

Adjust for Inflation

908 Devices Inc. Competitors Analysis of Net Interest Income

MASS · NASDAQ

Company	Net Interest Income	CAGR 3Y	CAGR 5Y	CAGR 10Y
908 Devices Inc. NASDAQ:MASS	816.00K	-49.3%	67.4%	N/A
RxSight, Inc. NASDAQ:RXST	2.47M	-8.9%	N/A	N/A
Perspective Therapeutics, Inc. AMEX:CATX	7.74M	108.8%	N/A	51.9%
Aclaris Therapeutics, Inc. NASDAQ:ACRS	7.64M	N/A	N/A	N/A
Cerus Corporation NASDAQ:CERS	-8.34M	N/A	N/A	N/A
CVRx, Inc. NASDAQ:CVRX	-5.83M	N/A	N/A	N/A
Sight Sciences, Inc. NASDAQ:SGHT	-1.17M	N/A	N/A	N/A
SANUWAVE Health, Inc. NASDAQ:SNWV	-6.25M	N/A	N/A	N/A
Capricor Therapeutics, Inc. NASDAQ:CAPR	3.21M	22.9%	N/A	N/A
Quanterix Corporation NASDAQ:QTRX	8.57M	-18.5%	N/A	N/A
Senseonics Holdings, Inc. NASDAQ:SENS	-753.00K	N/A	N/A	N/A

908 Devices Inc. Fair Value Envelope

MASS · NASDAQ

Our analysis suggests that MASS has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $8.66, this represents a potential HIDDEN relative to our calculated worth for 908 Devices Inc..

HIDDEN

Intrinsic Value

Current Price: $8.66

Related Guides

Blog Categories

Continue your MASS research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.